VNRX
VOLITIONRX LTD
$1.39
-22.35%
$11.7M
No data for this timeframe.
Vol
Market Cap$11.7M
Cap SizeNano Cap
Analyst ConsensusStrong Buy (80%)
Inst. Holders4 funds
Inst. Value$398.6K
Inst. Activity0 buys / 1 sells
Reddit Sentiment47° Neutral
SEC Reports9
Exchange NYSE·Sector In Vitro & In Vivo Diagnostic Substances·Inc. DE·CIK 0000093314·Prev Close $1.79
Recent Activity
Jun 9, 2026
SEC
VolitionRx is conducting a best-efforts offering of up to 2,960,000 shares of common stock and warrants to purchase up t
424B5 — Impact 7/10
Jun 5, 2026
SEC
VolitionRx filed a preliminary prospectus supplement for a best-efforts unit offering of common stock, pre-funded warran
424B5 — Impact 6/10
May 22, 2026
SEC
VolitionRx disclosed it violated the minimum market capitalization covenant on its $9.9M in aggregate senior secured con
8-K — Impact 7/10
Inst.
RENAISSANCE TECHNOLOGIES LLC — TRIM
25,300 shares ($6.5K)
Inst.
RENAISSANCE TECHNOLOGIES LLC — DOUBLED
78,000 shares ($52.9K)
May 13, 2026
earnings_calendar
VNRX Q1 2026 Earnings Scheduled — 2026-05-13
Price Targets
$20.21
+1385.8% upside
Strong Buy
Current $1.36
Low $16.83
Median $20.00
High $24.00
4 analysts
$16.83
$24.00
Analyst Ratings
2Strong Buy
6Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Apr 20, 2026 | D. Boral Capital | DOWNGRADE | Buy → Hold |
| Apr 2, 2026 | HC Wainwright & Co. | MAINTAIN | Buy → Buy |
| Mar 31, 2026 | D. Boral Capital | MAINTAIN | Buy → Buy |
| Mar 26, 2026 | D. Boral Capital | MAINTAIN | Buy → Buy |
| Mar 18, 2026 | D. Boral Capital | MAINTAIN | Buy → Buy |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.67 | $-0.67 — $-0.67 | 49% YoY | 1 |
| Next Q | $-0.58 ▲ +3.3% | $-0.58 — $-0.58 | 45% YoY | 1 |
| Current FY | $-2.62 ▼ -6.2% | $-2.62 — $-2.62 | 40% YoY | 1 |
| Next FY | $-1.15 ▼ -124.0% | $-1.15 — $-1.15 | 56% YoY | 1 |
Latest Reports
BEARISH
424B5
7/10
VolitionRx is conducting a best-efforts offering of up to 2,960,000 shares of common stock and warrants to purchase up t
Jun 9, 2026
BEARISH
424B5
6/10
VolitionRx filed a preliminary prospectus supplement for a best-efforts unit offering of common stock, pre-funded warran
Jun 5, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $391.7K | DOUBLED |
| RENAISSANCE TECHNOLOGIES LLC | $6.5K | TRIM |
| BANK OF AMERICA CORP | $245.00 | ADD |
| MORGAN STANLEY | $170.00 | NEAR_EXIT |
Reddit Sentiment
47°▲
Neutral
Bearish
Neutral
Bullish
4 institutional holders with $398.6K total value (1,556,973 shares) as of 2025-Q4. Top holders: VANGUARD, RENAISSANCE, BANK. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,530,048 | $391.7K | 98.3% | DOUBLED +130.1% |
| 2 | RENAISSANCE TECHNOLOGIES LLC | 25,300 | $6.5K | 1.6% | TRIM -67.6% |
| 3 | BANK OF AMERICA CORP /DE/ | 960 | $245.00 | 0.1% | ADD +47.0% |
| 4 | MORGAN STANLEY | 665 | $170.00 | 0.0% | NEAR_EXIT -91.7% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | TRIM | 78,000 | 25,300 | -67.6% | $6.5K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 20,500 | 78,000 | +280.5% | $52.9K | 2025-Q3 |
| UBS Group AG | DOUBLED | 1,377 | 14,827 | +976.8% | $10.1K | 2025-Q3 |
| VANGUARD GROUP INC | DOUBLED | 706,060 | 1,624,731 | +130.1% | $1.2M | 2025-Q2 |
| RENAISSANCE TECHNOLOGIES LLC | NEW | — | 20,500 | — | $15.6K | 2025-Q2 |
| UBS Group AG | NEAR_EXIT | 83,178 | 1,377 | -98.3% | $1.0K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | ADD | 619 | 910 | +47.0% | $692.00 | 2025-Q2 |
| MORGAN STANLEY | NEAR_EXIT | 10,900 | 900 | -91.7% | $513.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | EXIT | 72,592 | 0 | -100.0% | $0.00 | 2025-Q1 |
| CITADEL ADVISORS LLC | DOUBLED | 20,500 | 72,592 | +254.1% | $43.6K | 2024-Q4 |
| MORGAN STANLEY | DOUBLED | 2,900 | 10,900 | +275.9% | $6.5K | 2024-Q4 |
| MORGAN STANLEY | NEAR_EXIT | 89,225 | 2,900 | -96.7% | $1.7K | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
9 SEC filing reports analyzed. Sentiment: 0 bullish, 4 bearish, 1 mixed, 4 neutral. Avg impact: 5.2/10.
BEARISH
424B5
7/10
VolitionRx is conducting a best-efforts offering of up to 2,960,000 shares of common stock and warra
Jun 9, 2026
BEARISH
424B5
6/10
VolitionRx filed a preliminary prospectus supplement for a best-efforts unit offering of common stoc
Jun 5, 2026
BEARISH
8-K
7/10
VolitionRx disclosed it violated the minimum market capitalization covenant on its $9.9M in aggregat
May 22, 2026
NEUTRAL
8-K
4/10
VolitionRx reported Q1 2026 revenue of ~$1.0M, up from $0.2M a year ago, but operating loss was only
May 14, 2026
NEUTRAL
10-K/A
2/10
VolitionRx filed Amendment No. 1 to its 2025 Form 10-K solely to include Part III information (direc
Apr 30, 2026
NEUTRAL
8-K
3/10
VolitionRx filed a Certificate of Amendment to effect a 1-for-20 reverse stock split, effective Apri
Apr 28, 2026
BEARISH
8-K
8/10
VolitionRx received NYSE American's acceptance of its plan to regain compliance with continued listi
Apr 23, 2026
MIXED
8-K
6/10
VolitionRx reported full-year 2025 revenue of $1.7M (40% YoY growth) and Q4 revenue growth of 133%,
Apr 21, 2026
NEUTRAL
8-K
4/10
VolitionRx Limited announced a one-for-twenty reverse stock split of its common stock, effective Apr
Apr 17, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (80% buy). Based on 10 analysts: 2 strong buy, 6 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$20.21 mean target
+1385.8% upside
Strong Buy (1.50)
$16.83 Low
$24.00 High
| Metric | Value |
|---|---|
| Current Price | $1.36 |
| Target Low | $16.83 |
| Target Mean | $20.21 |
| Target Median | $20.00 |
| Target High | $24.00 |
| # Analysts | 4 |
| Recommendation | Strong Buy (1.50) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.67 | $-0.67 | $-0.67 | 48.7% | -0.5% | 0↑ 1↓ | $0.0B | 14.7% | 1 |
| Next Q 2026-09-30 |
$-0.58 | $-0.58 | $-0.58 | 45.1% | +3.3% | 1↑ 0↓ | $0.0B | -15.3% | 1 |
| Current FY 2026-12-31 |
$-2.62 | $-2.62 | $-2.62 | 40.4% | -6.2% | 1↑ 0↓ | $0.0B | 41.7% | 1 |
| Next FY 2027-12-31 |
$-1.15 | $-1.15 | $-1.15 | 56.1% | -124.0% | — | $0.0B | 134.2% | 1 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.670 | |
| 7d ago | $-0.700 | +0.030 |
| 30d ago | $-0.667 | -0.003 |
| 60d ago | $-0.667 | -0.003 |
| 90d ago | $-0.800 | +0.130 |
2 analyst firms have rated this stock: 0 upgrades, 1 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Apr 20, 2026 | D. Boral Capital | DOWNGRADE | Buy | Hold |
| Apr 2, 2026 | HC Wainwright & Co. | MAINTAIN | Buy | Buy |
| Mar 31, 2026 | D. Boral Capital | MAINTAIN | Buy | Buy |
| Mar 26, 2026 | D. Boral Capital | MAINTAIN | Buy | Buy |
| Mar 18, 2026 | D. Boral Capital | MAINTAIN | Buy | Buy |
| Jan 21, 2026 | D. Boral Capital | MAINTAIN | Buy | Buy |
| Jan 9, 2026 | D. Boral Capital | MAINTAIN | Buy | Buy |
| Dec 18, 2025 | D. Boral Capital | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 6 | 2 | 0 | 0 | 80% | |
| May 1, 2026 | 2 | 6 | 3 | 0 | 0 | 73% | |
| Apr 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Mar 1, 2026 | 2 | 7 | 2 | 0 | 0 | 82% | |
| Feb 1, 2026 | 2 | 7 | 3 | 0 | 0 | 75% | |
| Jan 1, 2026 | 2 | 7 | 3 | 0 | 0 | 75% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
47°
Neutral
Bearish
Neutral
Bullish
15 mentions
6 bullish
7 bearish
15 time periods
Reddit Sentiment History
| Date | Mentions | Sentiment | Bullish | Bearish | Threads |
|---|---|---|---|---|---|
| May 26, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 26, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 21, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 21, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 19, 2026 | 1 | 50° Neutral | 0 | 0 | 1 |
| May 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| May 15, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 15, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 11, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 11, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| May 6, 2026 | 1 | 40° Cool | 0 | 1 | 1 |
| Mar 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Mar 18, 2026 | 1 | 60° Warm | 1 | 0 | 1 |
| Feb 27, 2026 | 1 | 56° Neutral | 0 | 0 | 1 |
Recent Reddit Threads
$VNRX Short attack continues.
▲ 1
💬 1
⚡ 0.5
$VNRX Technical Setup Starting to Look Interesting 👀
▲ 1
💬 1
⚡ 0.5
$VNRX Q1 Financials released
▲ 1
💬 1
⚡ 0.5
$VNRX news
▲ 1
💬 1
⚡ 0.5
$VNRX News
▲ 1
💬 1
⚡ 0.5
TOP TRENDING stocks with potentially 1000% profits in 2026 just hit 52 weeks low ....VNRX stock easy money 💰 💸 💰 💸
▲ 1
💬 1
⚡ 0.5
VNRX could be an easy long for the next couple of years
▲ 1
💬 0
⚡ 0.0
May 13, 2026
earnings_calendar
VNRX Q1 2026 Earnings Scheduled — 2026-05-13
Apr 27, 2026
short_volume
Short Volume: VNRX — 62.1% short (0.7M / 1.2M)
Short: 745,952 | Exempt: 200 | TRF Vol: 1,201,812 | Short Ratio: 62.1% | Off-exchange volume (dark pool + OTC)
Apr 24, 2026
short_volume
Short Volume: VNRX — 64.4% short (0.7M / 1.1M)
Short: 703,196 | Exempt: 176,159 | TRF Vol: 1,091,440 | Short Ratio: 64.4% | Off-exchange volume (dark pool + OTC)
Apr 23, 2026
short_volume
Short Volume: VNRX — 66.1% short (1.0M / 1.5M)
Short: 987,014 | Exempt: 128,862 | TRF Vol: 1,494,298 | Short Ratio: 66.1% | Off-exchange volume (dark pool + OTC)
Apr 22, 2026
short_volume
Short Volume: VNRX — 67.6% short (1.1M / 1.6M)
Short: 1,078,556 | Exempt: 0 | TRF Vol: 1,596,031 | Short Ratio: 67.6% | Off-exchange volume (dark pool + OTC)
Apr 21, 2026
short_volume
Short Volume: VNRX — 68.0% short (0.6M / 0.9M)
Short: 631,067 | Exempt: 96,351 | TRF Vol: 928,535 | Short Ratio: 68.0% | Off-exchange volume (dark pool + OTC)
Apr 20, 2026
short_volume
Short Volume: VNRX — 59.3% short (0.9M / 1.5M)
Short: 861,081 | Exempt: 59,249 | TRF Vol: 1,453,001 | Short Ratio: 59.3% | Off-exchange volume (dark pool + OTC)
Apr 17, 2026
short_volume
Short Volume: VNRX — 71.5% short (1.5M / 2.1M)
Short: 1,482,127 | Exempt: 20,050 | TRF Vol: 2,071,719 | Short Ratio: 71.5% | Off-exchange volume (dark pool + OTC)
Apr 16, 2026
short_volume
Short Volume: VNRX — 65.4% short (0.9M / 1.4M)
Short: 908,708 | Exempt: 30,410 | TRF Vol: 1,390,338 | Short Ratio: 65.4% | Off-exchange volume (dark pool + OTC)
Apr 10, 2026
short_volume
Short Volume: VNRX — 65.5% short (1.5M / 2.3M)
Short: 1,492,015 | Exempt: 2,291 | TRF Vol: 2,276,565 | Short Ratio: 65.5% | Off-exchange volume (dark pool + OTC)
Apr 9, 2026
short_volume
Short Volume: VNRX — 59.2% short (0.9M / 1.5M)
Short: 861,275 | Exempt: 36,135 | TRF Vol: 1,455,298 | Short Ratio: 59.2% | Off-exchange volume (dark pool + OTC)
Apr 7, 2026
short_volume
Short Volume: VNRX — 57.4% short (1.1M / 1.9M)
Short: 1,103,539 | Exempt: 160,189 | TRF Vol: 1,922,928 | Short Ratio: 57.4% | Off-exchange volume (dark pool + OTC)
Apr 6, 2026
short_volume
Short Volume: VNRX — 60.7% short (1.1M / 1.9M)
Short: 1,139,193 | Exempt: 48,450 | TRF Vol: 1,876,091 | Short Ratio: 60.7% | Off-exchange volume (dark pool + OTC)
Apr 2, 2026
short_volume
Short Volume: VNRX — 55.2% short (2.1M / 3.8M)
Short: 2,069,294 | Exempt: 243,938 | TRF Vol: 3,751,870 | Short Ratio: 55.2% | Off-exchange volume (dark pool + OTC)
Mar 31, 2026
earnings_calendar
VNRX Q4 2025 Earnings After Market Close — 2026-03-31